Top compounds associated with response to CCK


Feature Type Standardized
Nominal ANOVA
mRNA temsirolimus CTRPv2 pan-cancer AAC -0.0064 0.9
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.005 0.9
mRNA nintedanib CTRPv2 pan-cancer AAC -0.005 0.9
mRNA ATRA CTRPv2 pan-cancer AAC 0.0046 0.9
mRNA BRD-K48477130 CTRPv2 pan-cancer AAC 0.0071 0.9
mRNA Sildenafil CTRPv2 pan-cancer AAC -0.0048 0.9
mRNA SNX-2112 CTRPv2 pan-cancer AAC 0.004 0.9
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.0044 0.9
mRNA XAV-939 GDSC1000 pan-cancer AAC 0.0047 0.9
mRNA cabozantinib CTRPv2 pan-cancer AAC -0.0044 0.9
Download CSV